Видео ютуба по тегу Valeant Portfolio

Bill Ackman on Valeant: Mistakes Were Made
Bill Ackman on Valeant: Mistakes Were Made
Valeant Planning to Acquire Medicis for $2.6 Billion
Valeant Planning to Acquire Medicis for $2.6 Billion
Valeant Pharmaceuticals - BNN
Valeant Pharmaceuticals - BNN
Valeant: Information Vacuums, Management Credibility and Investment Value
Valeant: Information Vacuums, Management Credibility and Investment Value
Valeant Pharmaceuticals BNN Prediction Video
Valeant Pharmaceuticals BNN Prediction Video
The Valeant Fraud Explained
The Valeant Fraud Explained
Valeant Falls Below $80 for First Time in Two Years
Valeant Falls Below $80 for First Time in Two Years
Big shake up at Valeant
Big shake up at Valeant
Valeant — spotting the dangers | Lex
Valeant — spotting the dangers | Lex
Is Valeant on the Verge of a Turnaround?
Is Valeant on the Verge of a Turnaround?
The Lesson of Valeant: Don’t get caught up in the euphoria
The Lesson of Valeant: Don’t get caught up in the euphoria
Valeant Stock Jumps After Reiterating Full-Year Forecast
Valeant Stock Jumps After Reiterating Full-Year Forecast
Valeant Pharmaceuticals CEO: New Products, New Name | Mad Money | CNBC
Valeant Pharmaceuticals CEO: New Products, New Name | Mad Money | CNBC
One year later, Chanos is still shorting Valeant
One year later, Chanos is still shorting Valeant
Valeant Pharmaceuticals Misses Earnings Estimates but Posts Better-Than-Expected Guidance
Valeant Pharmaceuticals Misses Earnings Estimates but Posts Better-Than-Expected Guidance
Valeant changes name to Bausch Health Companies, CEO explains why
Valeant changes name to Bausch Health Companies, CEO explains why
Valeant shares continue to plunge
Valeant shares continue to plunge
New To Valeant? Here's What Happened
New To Valeant? Here's What Happened
Valeant to File Financials by Deadline, Stock Rises
Valeant to File Financials by Deadline, Stock Rises
Valeant - price wars | Lex
Valeant - price wars | Lex